🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareCost-effectiveness analysis: GLP-1 agonists vs bariatric surgery (ICER 2026) — March 2026 Page 3

Cost-effectiveness analysis: GLP-1 agonists vs bariatric surgery (ICER 2026) — March 2026

Dr.EndoEP Thu, Mar 7, 2024 at 5:14 PM 15 replies 2,066 viewsPage 3 of 3
NurseLeah_Nash
Member
278
1,234
Sep 2024
Nashville, TN
Mar 10, 2024 at 12:28 PM#11
Dr.LeslieOBGYN said:
Denials are usually procedural rather than clinical, and the order that works reflects that.

This answered a question I did not know how to ask.

34 9RegAffairsDC, BiostatsBrad, PeptideSynthNJ and 31 others
Reply Quote Save Share Report
Dr.DermMIA
Member
456
2,123
May 2024
Miami, FL
Mar 12, 2024 at 10:15 PM#12

Clinical perspective, offered as context rather than as advice. Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third retelling.

33 8Dr.RenalNash, LipidDoc_ATL, BariatricNurseD and 30 others
Reply Quote Save Share Report
Dr.SleepRoch
Senior Member
1,123
5,678
Apr 2024
Rochester, MN
Mar 15, 2024 at 8:01 AM#13
pat_auckland said:
Timing surgery and anaesthesia around surgery: my surgeon required me to stop GLP-1 agonists 3 weeks before my scheduled procedure due to aspiration…

This is where I part company with the consensus forming above. The affordability discussion here usually stops at individual tactics. At list price this class is out of reach for most of the people who would benefit, and no amount of appeal strategy changes that — it is a pricing problem wearing a paperwork costume.

Last edited: Mar 15, 2024 at 12:01 PM
32 7Dr.NephBHM_UK, kim_atl_prep, sarah_TO and 29 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
quinn_sf
Member
489
2,123
Jun 2024
San Francisco, CA
Mar 17, 2024 at 5:45 PM#14

One concrete data point for the thread. Practical: whatever you change, write down the date and the reason. In three months the reason is what you will have forgotten, and the reason is what makes the record worth having.

31 6andrew_nyc, Dr.EndoEP, GraceAZ_72 and 28 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Mar 20, 2024 at 3:28 AM#15

Moderator note: a couple of off-topic posts removed. No action needed from anybody.

Last edited: Mar 20, 2024 at 5:28 AM
30 5PurityPaulOR, MaxMetOK, MounjBrad and 27 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register